Sensorion Croissance future
Future contrôle des critères 2/6
Sensorion's earnings are forecast to decline at 22.3% per annum while its annual revenue is expected to grow at 44.9% per year. EPS is expected to grow by 1.7% per annum.
Informations clés
-22.3%
Taux de croissance des bénéfices
1.7%
Taux de croissance du BPA
Biotechs croissance des bénéfices | 36.4% |
Taux de croissance des recettes | 44.9% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 20 May 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 8 | -40 | N/A | N/A | 2 |
12/31/2025 | 14 | -37 | -40 | -39 | 3 |
12/31/2024 | 14 | -24 | -21 | -20 | 3 |
12/31/2023 | 6 | -22 | -21 | -21 | N/A |
9/30/2023 | 6 | -23 | -22 | -21 | N/A |
6/30/2023 | 6 | -23 | -23 | -22 | N/A |
3/31/2023 | 5 | -23 | -23 | -22 | N/A |
12/31/2022 | 5 | -23 | -23 | -21 | N/A |
9/30/2022 | 5 | -22 | -19 | -18 | N/A |
6/30/2022 | 5 | -21 | -15 | -14 | N/A |
3/31/2022 | 4 | -18 | -13 | -13 | N/A |
12/31/2021 | 4 | -15 | -11 | -11 | N/A |
9/30/2021 | 4 | -13 | -12 | -11 | N/A |
6/30/2021 | 3 | -11 | -13 | -12 | N/A |
3/31/2021 | 3 | -10 | -9 | -9 | N/A |
12/31/2020 | 2 | -9 | -5 | -5 | N/A |
9/30/2020 | 2 | -10 | -8 | -8 | N/A |
6/30/2020 | 2 | -11 | -11 | -11 | N/A |
3/31/2020 | 2 | -12 | -12 | -12 | N/A |
12/31/2019 | 2 | -12 | -14 | -14 | N/A |
9/30/2019 | 2 | -12 | -12 | -12 | N/A |
6/30/2019 | 2 | -12 | -9 | -9 | N/A |
3/31/2019 | 2 | -12 | -11 | -11 | N/A |
12/31/2018 | 2 | -12 | -13 | -12 | N/A |
9/30/2018 | 2 | -12 | -11 | -11 | N/A |
6/30/2018 | 2 | -11 | -10 | -9 | N/A |
3/31/2018 | 2 | -10 | -9 | -9 | N/A |
12/31/2017 | 2 | -10 | -8 | -8 | N/A |
9/30/2017 | 1 | -9 | N/A | N/A | N/A |
6/30/2017 | 0 | -8 | N/A | N/A | N/A |
3/31/2017 | 0 | -8 | N/A | N/A | N/A |
12/31/2016 | 0 | -7 | N/A | N/A | N/A |
9/30/2016 | 0 | -7 | N/A | N/A | N/A |
6/30/2016 | 1 | -7 | N/A | -8 | N/A |
3/31/2016 | 0 | -6 | N/A | -6 | N/A |
12/31/2015 | 0 | -4 | N/A | -5 | N/A |
9/30/2015 | 0 | -4 | N/A | N/A | N/A |
6/30/2015 | 0 | -3 | N/A | -3 | N/A |
3/31/2015 | 0 | -3 | N/A | -3 | N/A |
12/31/2014 | 0 | -3 | N/A | -2 | N/A |
12/31/2013 | 0 | -2 | N/A | N/A | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: RFM is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: RFM is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: RFM is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: RFM's revenue (44.9% per year) is forecast to grow faster than the German market (5.2% per year).
Croissance élevée des revenus: RFM's revenue (44.9% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if RFM's Return on Equity is forecast to be high in 3 years time